(Q37821484)

23 August 2017

1 reference

title

Global prevailing and emerging pediatric pneumococcal serotypes (English)

1 reference

23 August 2017

E David G McIntosh

1

1 reference

PubMed ID

21162625

23 August 2017

Ralf R Reinert

series ordinal

2

1 reference

23 August 2017

1 January 2011

1 reference

Expert Review of Vaccines

23 August 2017

1 reference

23 August 2017

10

1 reference

23 August 2017

1

1 reference

23 August 2017

109-129

1 reference

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

23 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Progress in the prevention of pneumococcal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Pneumococcal serotypes in children in 4 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Impact of conjugate pneumococcal vaccines on antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Population-based impact of pneumococcal conjugate vaccine in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B,

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

The rise and fall of bacterial clones: Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Streptococcus pneumoniae serotype 19A in children, South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Seven-valent pneumococcal conjugate vaccines for developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region--current status and needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Population-based survey of antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from meningitis patients in Salvador, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Epidemiologic impact of blood culture practices and antibiotic consumption on pneumococcal bacteraemia in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Trends and geographical variation in invasive pneumococcal infections in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease in children up to 5 years of age in Poland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Etiology, antimicrobial susceptibility profiles, and mortality associated with bacterial meningitis among children in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Bacteriology of community acquired meningitis in Sfax, Tunisia (1993-2001)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Active epidemiologic surveillance of pneumonia and invasive pneumococcal disease in ambulatory and hospitalized infants in Cordoba, Argentina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Ten-year surveillance of pneumococcal infections in Temuco, Chile: implications for vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease in Costa Rican children: a seven year survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

The incidence of pediatric invasive pneumococcal disease in Chiba prefecture, Japan (2003-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease in New Zealand 1998-2005: capsular serotypes and antimicrobial resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Surveillance of pneumococcal meningitis among children in Sindh, southern Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease in Singapore children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Epidemiology of invasive pneumococcal infection in Taiwan: antibiotic resistance, serogroup distribution, and ribotypes analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Surveillance of pneumococcal-associated disease among hospitalized children in Khanh Hoa Province, Vietnam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal infections among hospitalized children in Bamako, Mali

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Surveillance of acute bacterial meningitis among children admitted to a district hospital in rural Mozambique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Population-based epidemiology of invasive pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serotype distribution of invasive pneumococcal disease during the first 60 days of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Streptococcus pneumoniae nasopharyngeal carriage in children attending day-care centers in the central region of Portugal, in the era of 7-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Pneumococcal serotypes causing pediatric meningitis in Turkey: application of a new technology in the investigation of cases negative by conventional culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Epidemiology of Streptococcus pneumoniae infection in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated from middle ear fluids of children aged 0-24 months with acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Temporal and spatial distribution of clonal complexes of Streptococcus pneumoniae isolates resistant to multiple classes of antibiotics in Belgium, 1997 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Resistance, serotype and genetic diversity of Streptococcus pneumoniae-resistant strains isolated in the West Pomerania region of Poland in the years 2001-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Prevenar vaccination: review of the global data, 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Characterization of penicillin intermediate serotypes of Streptococcus pneumoniae carried by human immunodeficiency virus-infected adults and healthy children in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Childhood invasive pneumococcal disease in Germany between 1997 and 2003: Variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.145

21 January 2018

Identifiers

DOI

10.1586/ERV.10.145

1 reference

23 August 2017

1 reference

PubMed ID

21162625